AbbVie Inc. shares closed virtually unchanged on Wednesday, finishing at $234.89 after a modest gain of $0.13, as investors assessed the company’s position in a competitive pharmaceutical landscape marked by patent expirations and pipeline developments.

The stability in trading reflected continued confidence in AbbVie’s core immunology franchise, particularly its flagship product Humira’s successors and growing oncology portfolio. The biopharmaceutical company has navigated the loss of exclusivity for its biggest product through strategic diversification and acquisitions.

AbbVie’s performance demonstrates resilience in a sector facing pricing pressures, regulatory scrutiny and competition from biosimilars. Its focus on specialty medicines and innovative therapies has supported revenue stability despite challenges in its legacy portfolio.

The company continues investing heavily in research and development, with emphasis on advancing treatments for autoimmune diseases, cancer and neurological disorders. Recent data readouts and regulatory milestones have generated interest among analysts and investors.

Key Product Performance

Humira, once the world’s best-selling drug, continues facing biosimilar competition, but AbbVie has successfully transitioned patients to newer immunology assets like Skyrizi and Rinvoq. These products have shown strong uptake and expanded indications, helping offset revenue declines.

Oncology remains a growth driver, with medicines like Imbruvica and Venclexta maintaining significant market presence. Pipeline candidates in solid tumors and blood cancers could provide additional catalysts in coming years.

Aesthetics and eye care products, including Botox and Restasis, contribute diversified revenue streams less exposed to patent cliffs. These consumer-facing businesses provide stability amid volatility in specialty pharmaceuticals.

Strategic Initiatives

AbbVie’s acquisition strategy has played a key role in portfolio renewal. Strategic purchases have bolstered capabilities in targeted therapy areas and expanded its global footprint.

The company maintains a disciplined approach to capital allocation, balancing R&D investment with shareholder returns through dividends and buybacks. Its strong cash flow generation supports these priorities.

Digital transformation and data analytics initiatives aim to enhance clinical development efficiency and commercial execution. These efforts position AbbVie to compete effectively in an increasingly technology-driven healthcare environment.

Industry Challenges

The pharmaceutical sector faces ongoing pressures from drug pricing debates, patent expirations and regulatory requirements. AbbVie’s experience navigating the Humira transition provides lessons for managing future losses of exclusivity.

Biosimilar competition has intensified, requiring innovative defense strategies and lifecycle management. Companies with robust pipelines and diversified portfolios are better positioned to weather these cycles.

Global healthcare spending trends, reimbursement policies and demographic shifts influence demand for AbbVie’s products. Aging populations in developed markets support long-term growth in chronic disease treatments.

Investment Outlook

AbbVie attracts investors seeking dividend growth and exposure to innovative medicines. Its yield and history of increases appeal to income-focused portfolios.

Valuation metrics reflect expectations for pipeline success and margin management. Risks include clinical trial outcomes, regulatory decisions and competitive dynamics.

Longer-term prospects remain positive given AbbVie’s established franchises and development programs. Successful commercialization of new therapies could drive renewed growth.

Analysts monitor upcoming clinical data and regulatory milestones closely. Execution on commercial strategies for key products will influence financial performance.

Research and Development Focus

AbbVie’s pipeline spans multiple therapeutic areas with several candidates in late-stage development. Advances in immunology, oncology and neuroscience could yield significant new treatments.

Collaboration with academic institutions and biotechnology companies expands innovation reach. These partnerships accelerate discovery while sharing development risks.

Precision medicine approaches and biomarker-driven therapies represent growing areas of emphasis. Such strategies aim to improve efficacy and safety profiles for patients.

Investment levels in R&D remain substantial, reflecting commitment to long-term value creation. Balancing near-term financial targets with pipeline investment requires careful management.

Corporate Responsibility and Sustainability

AbbVie engages in initiatives addressing healthcare access, diversity and environmental impact. These efforts enhance reputation and align with stakeholder expectations.

Patient assistance programs and global health partnerships demonstrate commitment beyond commercial activities. Such initiatives support brand value and talent attraction.

Sustainability reporting covers environmental footprint, supply chain practices and governance standards. Transparency in these areas has become increasingly important for investors.

Outlook

AbbVie’s recent share price performance reflects typical market dynamics in the healthcare sector. The company’s strategic direction and execution capabilities will determine its ability to deliver sustained growth.

Upcoming catalysts include clinical trial results, regulatory decisions and commercial updates. Management will continue balancing innovation investment with financial discipline.

The pharmaceutical industry’s evolution toward personalized medicine and advanced therapies creates opportunities for established players like AbbVie. Its strong foundation in immunology and expanding oncology presence position it favorably.

As the company navigates patent landscapes and competitive pressures, focus remains on delivering value for patients and shareholders. AbbVie’s track record suggests capability to adapt and thrive in changing healthcare environments.

Growth feels like the goal, right up until the new problems arrive. More staff, bigger premises and more equipment all bring obligations that were never an issue when the business was small, and most of them are easy to miss in the rush.

Here are the things business owners overlook when scaling, and what to put in place before they catch you out.

What do business owners overlook when scaling?

The duties that catch growing businesses out are usually the ones nobody flags in advance: statutory inspection of new equipment, gaps in insurance cover, tighter cashflow despite rising sales, and the HR obligations that arrive with a bigger team. Each is manageable on its own. Together, they account for most growing-pain headaches.

The items worth checking as you scale:

• Statutory examination duties on machinery and equipment
• Insurance that has quietly fallen behind the size of the business
• Cashflow that gets tighter as you grow, not looser
• HR and employment obligations that scale with headcount
• Premises duties like fire risk assessments and electrical safety

The first one is the one almost nobody sees coming.

New equipment brings new legal duties

When a business takes on bigger kit, it takes on responsibilities that go well beyond keeping it running. Certain equipment must be independently inspected by law, at set intervals, by a competent person. This is separate from servicing, and a quick check by a member of staff does not satisfy it.

Take on a forklift, a compressor or a mezzanine floor and you have taken on legal duties most owners have never heard of. Equipment like this needs regular statutory examination under regulations such as LOLER and PUWER, carried out by an independent inspection firm such as Nexus Examination, not just a quick once-over by a member of staff.

The intervals vary. Equipment used to lift people is typically examined every six months, other lifting equipment every twelve, and pressure systems under a written scheme. The report you receive is your evidence of compliance, so it matters as much as the inspection itself.

Cashflow gets harder, not easier

It catches owners by surprise, but growth eats cash. Bigger orders mean buying more stock and paying more wages before the customer has paid you, so a profitable business can still run short of money in the bank.

Watch the gap between money going out and money coming in. Keep a cash buffer, chase invoices properly, and be wary of taking on a large contract that ties up more cash than you can spare. Rising revenue is not the same as healthy cashflow.

The insurance you had is probably not enough

The cover that suited a one-person operation rarely fits a growing one. Employers’ liability insurance becomes a legal requirement the moment you hire staff, and the penalties for trading without it are steep.

Beyond that, more premises, vehicles, equipment and people change your exposure across the board. Review public liability, contents, business interruption and professional indemnity as you grow, rather than assuming the original policy still does the job.

HR obligations multiply with headcount

A handful of hires turns employment law into a real consideration. Written terms of employment, paying at least the national minimum or living wage, and enrolling eligible staff into a workplace pension all become non-negotiable.

As the team grows, so does the need for clear contracts, basic policies and a fair process for managing people. Accidents at work may also need reporting under RIDDOR. None of it is complicated, but it does need doing properly before a dispute forces the issue.

A quick checklist before your next growth step

Before you sign the lease, place the order or make the hire, run through this:

1. List every new piece of equipment and confirm what statutory examinations it requires.
2. Review every insurance policy against the current size of the business.
3. Forecast cashflow for the growth, not just the extra revenue.
4. Check your employment paperwork, pay rates and pension duties.
5. Sort premises duties such as fire risk assessments and electrical safety.

Work through it once and most of these become routine.

Scaling rewards the owners who plan for the obligations as well as the opportunities. The growth itself is rarely the hard part. The exposure comes from the duty you never knew had landed on your desk.

Lee Lorenzen is the founder and CEO of Cluster Solutions, a California-based research and development company focused on clustered water technology.

With a background in biology, pharmacology and biomedical consulting, Lorenzen has spent decades studying the structure of water and its role in hydration and cellular function.

Born and raised in Northern California as one of eight children, Lorenzen developed an early interest in science and the natural world. He earned a Bachelor of Arts from the University of California, Berkeley, before continuing graduate studies in biology at California State University, Fullerton. He also completed advanced graduate work under the supervision of Hoang Van Duc, M.D.

Lorenzen began his professional career in 1974 as a Graduate Instructor in Biology at Chapman College. He later joined the Department of Pharmacology at the University of California, Irvine, as a Research Associate. From 1976 to 1989, he worked in biomedical consulting, gaining experience in research and applied science.

A major turning point in his life came after his wife Stephanie developed serious health issues in the 1980s. The experience led Lorenzen to study water behaviour at the cellular level and eventually develop clustered water technology. In 1989, he founded Cluster Solutions to continue that research and product development.

Over the years, Lorenzen has received several U.S. patents related to clustered water processes, including U.S. Patents Nos. 5,711,950 and 6,033,678. His work has also been recognised by the Microsoft Alumni Foundation for research connected to AIDS and diabetes.

Today, Lorenzen continues to work with physicians, researchers and technical advisers while leading ongoing studies into water structure and hydration science.

Q: What first led you into science and research?

I grew up in Northern California as one of eight children, and I was always curious about how things worked. I enjoyed nature, biology and the outdoors from an early age. That interest eventually led me to study biology at the University of California, Berkeley. Later, I continued graduate studies in biology at California State University, Fullerton.

Early in my career, I worked as a Graduate Instructor in Biology at Chapman College and later as a Research Associate in the Department of Pharmacology at the University of California, Irvine. Those experiences gave me a strong foundation in research and scientific thinking.

Q: What originally sparked your interest in clustered water technology?

The biggest turning point was personal. My wife Stephanie became seriously ill during the 1980s. That experience pushed me to start asking different questions about health, hydration and biological systems.

At the time, I felt there were gaps in the traditional models I was studying. I remember thinking, “Something is missing with this model.” That thought stayed with me for years.

Eventually, I became interested in the structure of water itself and how water behaves inside living cells.

Q: Was there a specific moment when your research changed direction?

Yes. I remember reading work by Nobel Prize winner Albert Szent-Györgyi about cellular water. That research helped connect several ideas for me.

Later, I began studying natural healing springs around the world, including Lourdes in France. I noticed geological similarities in places where people reported unusual water properties. That led me deeper into research on water clustering and molecular structure.

The goal became understanding whether those natural conditions could be reproduced in a stable and controlled way.

Q: You founded Cluster Solutions in 1989. What was your original vision for the company?

The goal was to create a company focused entirely on research and development related to clustered water technology. I wanted a structure where the science could continue long-term.

My role has always been both scientific and operational. I oversee research direction, product development and strategic partnerships. I also stay directly involved in testing and evaluating the technology.

Q: What makes clustered water different from other hydration products?

Most hydration products focus on adding ingredients to water, such as minerals, electrolytes or supplements. Our focus has always been on the structure of water itself.

We study how water molecules organise and how that organisation may affect hydration and nutrient transport at the cellular level. The research is centred on stabilising smaller molecular clusters rather than simply adding substances.

Q: Has it been difficult working in a field that challenges traditional thinking?

At times, yes. When ideas challenge existing assumptions, they are often questioned early on. That is part of scientific history.

You can look at people like Otto Ampferer or Jacques Benveniste. Their work faced resistance before parts of it were revisited later. Even major scientific figures have made incorrect predictions about what was or was not possible.

That does not mean every new idea is correct. But it does mean research should be evaluated carefully and openly.

Q: How do you approach scientific credibility and long-term trust?

Consistency and transparency are very important. I work with physicians, researchers and technical advisers who can independently evaluate results.

I also believe in documentation and long-term testing. Research is not a one-time event. It is a continuous process of refinement, feedback and observation.

Over time, trust comes from staying involved and being willing to answer difficult questions directly.

Q: What challenges have shaped your leadership approach?

Patience has probably been the biggest lesson. Research takes time. Acceptance takes time. You have to stay focused on the work itself rather than short-term reactions.

I have also learned that leadership requires structure. Discovery alone is not enough. You need systems for testing, collaboration and maintaining scientific integrity over many years.

Q: What keeps you motivated after all these years?

Research and development still motivate me. I enjoy solving problems and continuing to learn.

I also value hearing feedback from people who use the products or study the technology. Those conversations often lead to new ideas or new areas of research.

Outside work, I enjoy spending time with my family and grandchildren and being outdoors. That balance is important.

Q: What advice would you give to people pursuing unconventional ideas?

Be prepared for scepticism. Document your work carefully and stay committed to the process.

Many discoveries take years to be fully understood. Patience, persistence and integrity matter more than quick recognition.

To put it simply, the GTA franchise is one of the biggest and most profitable entertainment properties in history.

GTA 5 has sold nearly 230 million copies, making it one of the best-selling games of all time – which has generated billions of dollars in revenue for Rockstar.

The game’s sandbox gameplay, where players can explore vast open worlds with considerable freedom – sometimes controversially – has seen it be continuously lauded as the ultimate expression for what the interactive medium can do.

Freelance video games journalist Vic Hood said each entry in the series “continued to push technical and gameplay boundaries”, with GTA Online helping to “pioneer the live service model as we know it”.

She added that the games were also “extremely culturally relevant” too.

“Rockstar has always had its finger on the pulse of music, entertainment, societal, political, celebrity, and online culture trends, and they’ve never shied away from satirising these things in GTA games,” she said.

British gaming entrepreneur Sir Ian Livingstone told the BBC’s Today programme that the series, originally developed in Scotland, was “bigger than any film or song” and an “incredible achievement in interactive software”.

Speculation as to how a sixth game can top even the gigantic heights of its predecessor has meant that any latest news, no matter how small, has been met with a flurry of hype and excitement.

Both of GTA 6’s previous gameplay trailers currently have a total of roughly 447 million views combined.

In its last financial year it increased its presence outside of Wales in the south west of England and London

Independent insurance, risk and insurtech business Thomas Carroll Group is continuing to drive revenues and its headcount.

In its financial to the end of December, 2025 the Caerphilly-based business saw revenues rise 4% from £15.6m in 2024 to more than £16.2m. This was driven by organic growth. Profit before tax reduced from £1.6m to £1.3m as a result of increased expenditure driven by continued investment in people, infrastructure and growth initiatives, alongside inflationary cost pressures.

The group maintained a strong balance sheet, underlining its financial resilience and enabling continued investment in strategic growth initiatives.

The average number of employees increased to 186 in 2025 from 176 in 2024, proving continued recruitment to support growth and service delivery across the group.

During the year, the business, which has operated as an employee ownership trust since 2023, expanded its regional footprint and operational capacity, strengthening its ability to support clients across the UK.

The group progressed its entry into the south west of England marketplace through the opening of its Bristol office in May 2025, alongside significant recruitment activity to support growth. At its Bristol office capacity was increased during the year to support expansion, while in

London further recruitment led to a move into larger premises.

Chief executive of Thomas Carroll, Rhys Thomas, said: “These figures demonstrate that investment in people remains central to our strategy. We continue to prioritise capability development, retention and succession planning, recognising that the quality of advice we provide and the experience our clients receive are directly linked to our people.

“Operationally, we maintain a strong focus on efficiency, governance and regulatory compliance, ensuring our processes and controls evolve alongside the scale and complexity of the business.”

“While profit before tax reduced during the year, this reflects a deliberate and significant investment programme that has been fully supported by our employee ownership trust structure. We are attractive to talented people because of the certainty of our future, our independence and our ability to remain in control of our own destiny.

“The growth we have achieved across our regional offices, together with our continued investment in innovation, positions us strongly for the future. These results reinforce our commitment to sustainable growth and a long-term focus, further strengthened by our transition to employee ownership.”

A new generation of AI-native platforms is transforming customer relationship management from a record-keeping tool into an autonomous driver of business outcomes — and Australian enterprises are beginning to take notice.

Australian businesses are collecting more customer data than at any point in their history. Sales interactions, support tickets, marketing touchpoints, e-commerce behaviour — the volume of signals that companies now capture would have seemed extraordinary a decade ago. The problem, for many organisations, is not a lack of data. It is the inability to act on it quickly enough.

Customer expectations have shifted accordingly. Buyers in financial services, retail, and manufacturing increasingly expect personalised, timely responses that reflect an understanding of their history and needs. To deliver that experience consistently and at scale, organizations need systems that can process customer signals and respond to them in real time.

That operational gap is driving a significant reassessment of how Australian enterprises approach customer relationship management. The question is no longer simply which platform to use, but what kind of platform is needed for a business environment in which speed and personalisation are baseline requirements.

What CRM Is — And Why It Is Changing

At its core, CRM software is designed to help organisations manage and analyse their interactions with existing and prospective customers. Traditionally, that has meant a centralised database of contacts, deal histories, and communication records — a system of record that sales, marketing, and service teams can query and update.

For much of the past two decades, this model served businesses adequately. The major platforms in the space built large ecosystems around this foundational capability, adding layers of reporting, integration, and workflow automation over time.

The arrival of enterprise-grade artificial intelligence is now changing the underlying logic of what CRM systems are expected to do. Rather than waiting for a sales representative to query a database or a manager to review a pipeline report, AI-native platforms are designed to surface insights proactively, automate routine interactions, and in some configurations, act on customer signals without requiring human initiation.

This shift from passive data repository to active operational system is what analysts and vendors are increasingly describing as the transition from traditional CRM to agentic, or AI-native CRM.

The Rise of AI Agents in CRM

The concept of AI agents, defined as software systems capable of autonomously executing multi-step tasks based on specified goals, has moved from research papers into enterprise software with notable speed. According to Gartner, fewer than 5% of enterprise applications included task-specific AI agents in 2025. By the end of 2026, Gartner projects that figure will reach 40%.

The implications for CRM are substantial. In practice, AI agents embedded in customer management platforms can handle tasks such as lead qualification and prioritisation, appointment scheduling, follow-up sequencing, and case routing, all of which previously consumed significant hours of skilled employee time.

The market response has been correspondingly strong. IDC projects that year-on-year spending on artificial intelligence will grow by 31.9% between 2025 and 2029, reaching $1.3 trillion globally by the end of that period. A significant share of that investment is directed toward agentic AI applications, including CRM automation.

Gartner’s 2026 CIO and Technology Executive Survey found that while only 17% of organisations had deployed AI agents to date, more than 60% expected to do so within two years, representing the steepest adoption curve among all emerging technologies tracked in the survey. Analysts note, however, that speed of adoption will need to be balanced against governance maturity: Gartner separately estimated that more than 40% of agentic AI projects risk cancellation by 2027 due to unclear business value or inadequate risk controls.

What This Means for Australian Businesses

Australia’s CRM market is currently valued at approximately USD 2 billion and is projected to grow at a compound annual rate of around 10% through to 2033, according to IMARC Group. The sectors driving adoption most aggressively are financial services, retail, and manufacturing, industries where customer volume is high, margins on individual interactions are meaningful, and the cost of losing a relationship to a faster-responding competitor is material.

For financial services organisations in particular, the integration of AI into CRM workflows addresses a specific operational pressure: regulatory obligations demand accurate, auditable records, while market competition demands faster and more personalised client engagement. AI-native platforms that combine workflow automation with compliance-aware governance are increasingly seen as a practical resolution to that tension.

Retail businesses face a related but distinct challenge. The growth of e-commerce has compressed the window in which a timely follow-up or personalised recommendation can influence a purchase decision. Manual CRM processes are structurally unable to operate at the speed required. AI-native systems that can detect a behavioural signal and trigger a contextualised response within minutes are therefore attracting serious evaluation.

Mid-market manufacturers and distributors have historically been underserved by CRM vendors that focus on either large enterprise or SME deployments. The emergence of no-code configuration tools within AI-native platforms is helping to reduce barriers to adoption for this segment. Businesses that previously lacked the IT resources to customise and maintain a CRM implementation can now build and modify workflows without specialist development skills.

One Platform Shaping the Agentic CRM Category

Among the vendors positioning themselves at the intersection of AI and no-code CRM, Creatio has drawn notable attention from industry analysts. The company was recognised as a Leader in the Gartner Magic Quadrant for B2B Marketing Automation Platforms for the fifth consecutive year in 2025, and as a Visionary in the Gartner Magic Quadrant for Sales Force Automation Platforms the same year.

Independent research firm Nucleus Research, which interviewed Creatio customers to assess real-world outcomes, found that the platform’s no-code capabilities deliver a 37% reduction in total cost of ownership compared to alternative solutions, alongside a 70% reduction in implementation timelines and a 61% reduction in lead response time for sales teams. Users also reported measurable improvements in organisational agility and the ability to run continuous improvement initiatives without relying on specialist development resources.

Creatio’s architecture combines a no-code development environment with natively embedded AI agents, enabling organisations to build and modify CRM workflows without writing code. The company reported 40% year-on-year revenue growth in 2025, continuing its accelerated expansion among enterprise customers across financial services, manufacturing, and the public sector, with organisations including Nasdaq, Allianz, MetLife, and E.ON Next among those selecting the platform.

The platform’s real-world impact has been documented across a range of industries. BSN Sports, a US distributor of sporting equipment serving more than 150,000 institutional customers, reported a 60% increase in sales book size per representative over five years following its implementation of Creatio, alongside 100% user adoption across its sales organisation.

What Australian Organisations Should Evaluate

For Australian businesses beginning to assess AI-native CRM options, analysts and practitioners generally point to four criteria as foundational to a sound evaluation.

Integration flexibility is frequently the first consideration. A CRM platform, however capable in isolation, delivers limited value if it cannot connect cleanly with the ERP, marketing automation, and data warehousing systems already in use. Organisations should assess both the depth of available native integrations and the availability of open APIs for custom connections.

No-code configurability has become a significant differentiator as businesses seek to reduce dependence on specialist development resources. Platforms that allow business users to modify workflows, build automation rules, and deploy new capabilities without requiring IT involvement can materially reduce both implementation timelines and ongoing maintenance costs.

AI governance and transparency is emerging as a critical selection criterion, particularly for regulated industries. As AI agents take on a greater share of customer-facing decision-making, organisations need visibility into how those decisions are made, the ability to audit outcomes, and clear controls over which tasks agents are authorised to execute autonomously.

Total cost of ownership over a three-to-five year horizon, accounting for licensing, implementation, customisation, and ongoing support, frequently tells a different story than headline subscription pricing. Platforms with strong no-code capabilities tend to reduce ongoing professional services dependency, which can represent a meaningful cost advantage over time.

Looking Ahead

The shift from traditional CRM to AI-native platforms is no longer a distant prospect for Australian businesses. The transition is already under way across the market segments facing the greatest competitive pressure to deliver superior customer experiences. The organisations that move thoughtfully and early are likely to accumulate structural advantages that compound over time: faster response cycles, more efficient sales operations, and customer data assets that become progressively more valuable as AI capabilities improve.

The technology is maturing rapidly. What has changed is the availability of platforms that make sophisticated AI-native CRM accessible to organisations without large technology teams or significant IT budgets. For Australian businesses still operating legacy systems, that accessibility is both an opportunity and, over a medium-term horizon, a strategic risk if competitors move first.

The question for most enterprises is no longer whether to modernise their approach to customer relationship management, but how quickly they can do so without disrupting the operations they already depend on.

Sources

• Gartner, Hype Cycle for Agentic AI, 2026

• Gartner, CIO and Technology Executive Survey, 2026

• Gartner, Magic Quadrant for B2B Marketing Automation Platforms, September 2025

• IMARC Group, Australia Customer Relationship Management Market, 2025–2033

• Creatio, Marks a Landmark Year of AI Innovation and Accelerated Global Growth, January 2026

• Forrester Wave: CRM Software for Financial Services, Q1 2025

• Nucleus Research, Creatio’s No-Code Capabilities Reduce TCO by 37 Percent, April 2025

• Creatio, Company News and Investor Announcements, 2024–2025

• BSN Sports / Creatio, Customer Success Case Study, 2024

• Creatio Glossary: CRM Software

For UK small businesses, the question of how long to hold onto customer data is not as simple as picking a number and sticking with it. There is no single fixed retention period under UK GDPR.

Instead, the law requires that personal data be kept only for as long as necessary for the purpose it was originally collected — and businesses must be able to justify that decision in writing.

This places a real operational burden on SMBs. A business that collects email addresses for a newsletter campaign, stores payment details for recurring orders, and logs support conversations is already dealing with several categories of data, each with its own appropriate lifespan. Getting this wrong is not a minor administrative failing — it is a compliance risk with financial consequences.

What GDPR Says About Data Retention

UK GDPR’s storage limitation principle is clear in direction but silent on specifics. It tells organisations not to hold personal data longer than necessary, but it does not tell them exactly how long “necessary” means for any given category. The practical implication is that every SMB needs a documented retention policy that explains, category by category, why data is being kept and when it will be deleted or anonymised.

Standard business records — invoices, contracts, VAT-related documents — often need to be retained for six or seven years under tax and accounting rules. Consumer-facing records, however, are a different matter. Inactive customer accounts, expired marketing leads, and closed support tickets should be reviewed separately and deleted once they no longer serve a clear, documented purpose. Without that discipline, data quietly accumulates, and so does risk.

Which Data Types Carry Stricter Limits

Not all consumer data deserves the same retention window. Payment and financial records carry longer obligations because of tax law and potential disputes. Marketing consent records should be kept long enough to demonstrate compliance with PECR if challenged, but deleted when consent lapses. Special category data — which includes health, biometric, and certain demographic information — requires a higher standard of justification for retention and tighter access controls throughout its life.

Digital-native businesses, including online platforms and subscription services, now face growing user expectations around data minimisation. Sectors that have developed strong frameworks around user transparency offer useful benchmarks — fintech apps, healthtech platforms, and iGaming services like betting in the UK without registration have all been pushed by regulation to minimise data collected upfront, reshaping how compliance pressure translates into practical data handling across industries.

According to a Computer Weekly data retention analysis, a category-by-category approach rather than a blanket policy is now widely regarded as best practice for UK organisations.

Industries Where Retention Rules Differ

Sector-specific rules complicate matters considerably for businesses that assume general GDPR guidance is enough. Healthcare providers may need to retain patient-adjacent records for years beyond what a standard retail business would ever consider. Financial services firms operating under FCA supervision and anti-money-laundering regulations face their own mandatory minimums that override what GDPR alone would suggest. Payroll and HR outsourcing firms sit in similarly complex territory.

The Data (Use and Access) Act 2025, which became law on 19 June 2025, has begun updating and formalising parts of the UK GDPR framework. As detailed in Osborne Clarke’s legal analysis, the Act puts some ICO guidance points onto a firmer statutory footing, including proportionality expectations around subject access requests. For sector-specific SMBs, this means the compliance baseline is now slightly higher than it was a year ago.

Steps SMBs Should Take Right Now

The first practical step is building a data map — a clear record of what personal data the business holds, where it sits, why it was collected, and how long it will be kept. Without this foundation, it is impossible to enforce a retention schedule or respond credibly to a subject access request or complaint. This does not require specialist software; a well-maintained spreadsheet can serve the purpose for most small businesses.

The financial case for action is compelling. Last year, the average cost of a data breach for a UK SME reached £6,400, according to the Government’s Cyber Security Breaches Survey. Holding unnecessary data directly inflates that risk. SMBs that set firm deletion or anonymisation dates, review their retention schedules annually, and document their reasoning are not just meeting legal requirements — they are actively reducing their exposure to a cost that can be genuinely damaging at small-business scale.